Parkinson's disease and Alzheimer's disease: New neurochemical parallels

to

[1]  D. Price,et al.  Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease , 1988, Neurology.

[2]  D L Price,et al.  Aminergic systems in Alzheimer's disease and Parkinson's disease , 1987, Annals of neurology.

[3]  D. Price,et al.  Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy , 1987, Neurology.

[4]  D. Price,et al.  Cellular pathology in Alzheimer's and Parkinson's diseases , 1986, Trends in Neurosciences.

[5]  K. Jellinger.  Cellular pathology in alzheimer's and parkinson's diseases , 1986, Trends in Neurosciences.

[6]  P. Emson,et al.  Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type , 1986, Neuroscience Letters.

[7]  Joseph B. Martin,et al.  Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease , 1986, Annals of neurology.

[8]  J. Coyle,et al.  Nicotinic acetylcholine binding sites in Alzheimer's disease , 1986, Brain Research.

[9]  D. Price,et al.  Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease , 1986, Nature.

[10]  P J Whitehouse,et al.  The concept of subcortical and cortical dementia: Another look , 1986, Annals of neurology.

[11]  G. Reynolds,et al.  Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations. , 1985, JAMA.

[12]  V. Chan‐Palay,et al.  II. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's‐type dementia , 1985, The Journal of comparative neurology.

[13]  B. Chronwall,et al.  Pancreatic polypeptide immunoreactivity in rat brain is actually neuropeptide Y , 1985, Neuroscience.

[14]  T. Crow,et al.  Dissociation of neuropeptide Y and somatostatin in Parkinson's disease , 1985, Brain Research.

[15]  T. O'donohue,et al.  Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons , 1984, Neuroscience Letters.

[16]  C. Marsden,et al.  HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE? , 1984, The Lancet.

[17]  R. Mayeux,et al.  Contribution of perceptual motor dysfunction to construction and tracing disturbances in Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[18]  F. Boller,et al.  Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. , 1984, Archives of neurology.

[19]  Y. Agid,et al.  Somatostatin and dementia in Parkinson's disease , 1983, Brain Research.

[20]  D L Price,et al.  Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.

[21]  T. Hökfelt,et al.  Coexistence of somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivity in some forebrain neurons , 1982, Neuroscience.

[22]  R. Mayeux,et al.  Depression, intellectual impairment, and Parkinson disease , 1981, Neurology.

[23]  P. Davies,et al.  Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile Dementia of the Alzheimer type , 1981, Neurobiology of Aging.

[24]  U. Roessmann,et al.  Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations , 1980, Annals of neurology.

[25]  Lipton Ra,et al.  Letter: Factor VIII. , 1973, Lancet.

[26]  D L Price,et al.  Alzheimer's disease and related dementias: selective involvement of specific neuronal systems. , 1985, CRC critical reviews in clinical neurobiology.